Addressing the Debate: Panel Size & Access
Time: 4:00 pm
day: Track B - Day 2 pm
• Playoff between larger panels and smaller and the impacts on reimbursement and access to diagnostic testing
• How is the current reimbursement system affecting partnering and panel design decisions which may be to the detriment of the technical functioning of panels used for biomarker detection?
• Centralised biomarker testing models – where do we see the future of CDx development?